Kawasaki Disease clinical trials at University of California Health
2 research studies open to eligible people
Kawasaki MATCH Trial
open to eligible people ages up to 17 years
Evaluating the impact of a machine-learning clinical decision support tool on provider practice when evaluating febrile patients with Kawasaki Disease (KD) and non-KD illnesses.
at UCSD
Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
open to eligible people ages 0-20
The study investigators are interested in learning more about how drugs, that are given to children by their health care provider, act in the bodies of children and young adults in hopes to find the most safe and effective dose for children. The primary objective of this study is to evaluate the PK of understudied drugs currently being administered to children per SOC as prescribed by their treating provider.
at UCLA
Our lead scientists for Kawasaki Disease research studies include Michael Gardiner Jaime Deville.
Last updated: